Your browser doesn't support javascript.
loading
White matter predicts functional connectivity in premanifest Huntington's disease.
McColgan, Peter; Gregory, Sarah; Razi, Adeel; Seunarine, Kiran K; Gargouri, Fatma; Durr, Alexandra; Roos, Raymund A C; Leavitt, Blair R; Scahill, Rachael I; Clark, Chris A; Tabrizi, Sarah J; Rees, Geraint; Coleman, A; Decolongon, J; Fan, M; Petkau, T; Jauffret, C; Justo, D; Lehericy, S; Nigaud, K; Valabrègue, R; Choonderbeek, A; Hart, E P T; Hensman Moss, D J; Crawford, H; Johnson, E; Papoutsi, M; Berna, C; Reilmann, R; Weber, N; Stout, J; Labuschagne, I; Landwehrmeyer, B; Orth, M; Johnson, H.
Afiliação
  • McColgan P; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Gregory S; Wellcome Trust Centre for Neuroimaging UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Razi A; Wellcome Trust Centre for Neuroimaging UCL Institute of Neurology London WC1N 3BG United Kingdom; Department of Electronic Engineering NED University of Engineering and Technology Karachi Pakistan.
  • Seunarine KK; Developmental Imaging and Biophysics Section UCL Institute of Child Health London WC1N 1EH United Kingdom.
  • Gargouri F; APHP Department of Genetics Groupe Hospitalier Pitié-Salpêtrière and ICM (Brain and Spine Institute) INSERM U1127 CNRS UMR 7225 Sorbonne Universités - UPMC Université Paris VI UMR_S 1127 Paris France.
  • Durr A; APHP Department of Genetics Groupe Hospitalier Pitié-Salpêtrière and ICM (Brain and Spine Institute) INSERM U1127 CNRS UMR 7225 Sorbonne Universités - UPMC Université Paris VI UMR_S 1127 Paris France.
  • Roos RA; Department of Neurology Leiden University Medical Centre Leiden 2300RC The Netherlands.
  • Leavitt BR; Department of Medical Genetics Centre for Molecular Medicine and Therapeutics University of British Columbia 950 West 28th Avenue Vancouver BC V5Z 4H4 Canada.
  • Scahill RI; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Clark CA; Developmental Imaging and Biophysics Section UCL Institute of Child Health London WC1N 1EH United Kingdom.
  • Tabrizi SJ; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom; National Hospital for Neurology and Neurosurgery Queen Square London WC1N 3BG United Kingdom.
  • Rees G; Wellcome Trust Centre for Neuroimaging UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Coleman A; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Decolongon J; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Fan M; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Petkau T; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Jauffret C; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Justo D; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Lehericy S; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Nigaud K; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Valabrègue R; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Choonderbeek A; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Hart EP; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Hensman Moss DJ; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Crawford H; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Johnson E; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Papoutsi M; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Berna C; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Reilmann R; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Weber N; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Stout J; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Labuschagne I; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Landwehrmeyer B; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Orth M; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
  • Johnson H; Department of Neurodegenerative Disease UCL Institute of Neurology London WC1N 3BG United Kingdom.
Ann Clin Transl Neurol ; 4(2): 106-118, 2017 02.
Article em En | MEDLINE | ID: mdl-28168210
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Clin Transl Neurol Ano de publicação: 2017 Tipo de documento: Article